<GlossaryTerm id="CDR0000488417"><TermName>nitric oxide-releasing acetylsalicylic acid derivative</TermName><TermPronunciation>(NY-trik OK-side-reh-LEE-sing A-seh-til-SA-lih-SIH-lik A-sid deh-RIH-vuh-tiv)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the prevention of colorectal cancer. It is a form of aspirin that gives off nitric oxide gas and is less irritating to the lining of the stomach than plain aspirin. It is a type of nonsteroidal anti-inflammatory drug (NSAID). Also called NCX 4016.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000718417" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;nitric oxide-releasing acetylsalicylic acid derivative&quot;" language="en" id="_3"/><MediaLink ref="CDR0000718416" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;derivado del ácido acetilsalicílico liberador de óxido nítrico&quot;" language="es" id="_4"/><SpanishTermName>derivado del ácido acetilsalicílico liberador de óxido nítrico</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para la prevención de cáncer colorrectal. Es una forma de aspirina que libera gas de ácido nítrico y es menos irritante para el revestimiento del estómago que la aspirina simple. Es un tipo de medicamento antiinflamatorio no esteroideo (AINE). También se llama NCX 4016.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-12-01</DateFirstPublished></GlossaryTerm>
